GODAVARI DRUGS LTD. - Announcement Under Regulation 30
18 May 2022
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and on the recommendations of the Nomination and Remuneration Committee, Board of Directors & Shareholders at their Meeting held today i.e. on May 16, 2022, has taken following decisions:
i. Continuation of Mr. Mukund Kakani (DIN: 00104646) as Managing Director upon attaining age of Seventy years.
ii. Re. appointment of Mr. Mohit Jaju (DIN: 00076657) as Wholetime Director and CFO of the Company.
Source:
BSE India